If You Invested in Simplify VettaFi Private Credit Strategy ETF (PCR)
Looking for the current price? See the PCR quote & overviewWhat $1,000 or $10,000 in PCR Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Sep 23, 2025 |
|---|---|---|---|---|
| $1,000 | — | — | — | $764 -24% |
| $10,000 | — | — | — | $7,641 -24% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for PCR$1,000 Investment Over Time
PCR vs S&P 500Year-by-Year Returns
PCR annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2025 | $25.02 | $23.05 | -7.9% | -7.9% |
| 2026 | $23.00 | $19.12 | -16.9% | -23.6% |
About Simplify VettaFi Private Credit Strategy ETF
NYSE
The Simplify VettaFi Private Credit Strategy ETF (NYSE Arca: PCR) is an exchange-traded fund launched by Simplify Asset Management Inc. It is described as a private credit strategy ETF that seeks to give investors exposure to private credit markets while incorporating a dedicated credit hedge. PCR is part of Simplify’s alternatives and income-focused ETF lineup and is listed on the NYSE Arca exchange.
According to Simplify, PCR’s private credit strategy seeks to track the returns of the VettaFi Private Credit Index. This index is derived from a universe of Business Development Companies (BDCs) and publicly traded Closed-End Funds (CEFs) that are primarily engaged in private credit. Potential index constituents must meet stated minimum market capitalization and liquidity requirements and are evaluated using proprietary percentile scores based on volatility and dividend yield.
A key feature highlighted for PCR is its proprietary credit hedging strategy. The fund employs a hedge that goes long stocks with high-quality metrics and short stocks that exhibit low-quality metrics. Simplify notes that this hedge has historically shown a positive correlation with credit spreads and a historical positive carry. The goal of this structure is to pair private credit exposure with a managed approach to credit risk, particularly during adverse credit events or periods of credit spread widening.
As an actively managed ETF, PCR is subject to the risk that its strategy may not achieve the intended results. The fund may use derivative instruments, including swaps and options, and may invest in other ETFs. The disclosures emphasize that derivatives can involve risks different from, or greater than, investing directly in securities, including counterparty risk, valuation risk, and the possibility that changes in derivative values may not closely track the underlying asset, rate, or index.
The risk disclosures for PCR also reference exposure to high yield debt ("junk bonds"), credit risk, and liquidity risk. High yield securities and unrated securities of similar credit quality are described as speculative with respect to an issuer’s ability to make principal and interest payments and may be more volatile than higher-rated securities. The fund is identified as non-diversified, meaning it may invest a larger portion of its assets in fewer issuers than a diversified fund, which can increase fluctuations in its share price.
Fixed income-related risks are also highlighted, including the potential impact of rising interest rates on bond prices and fund value, as well as prepayment risk and credit risk. Swaps used in the strategy are noted as being subject to tracking risk if they do not perfectly substitute for the instruments they are intended to hedge or replace.
The disclosures characterize PCR as a recently organized management investment company with no operating history at the time of its introduction. As with other ETFs, investors are encouraged to review the fund’s prospectus or summary prospectus for detailed information on investment objectives, risks, charges, and expenses, and are reminded that an investment in the fund involves risk, including possible loss of principal.
In a later announcement, Simplify Asset Management reported that the previously disclosed net asset values (NAVs) per share of the Simplify VettaFi Private Credit Strategy ETF for a specified period were restated due to incorrect swaps financing rates. The notice provided a schedule of revised and original NAVs and indicated that the adjustments were effective as of a stated date. This event underscores the role of derivatives and financing assumptions in the fund’s valuation process.
Simplify Asset Management Inc. is described in the fund’s communications as a Registered Investment Adviser founded in 2020. The firm states that it focuses on helping advisors address portfolio challenges through options-based strategies that take into account real-world investor needs, market behavior, and the non-linear characteristics of options.
Frequently Asked Questions
Simplify VettaFi Private Credit Strategy ETF investment returns
How much would $1,000 invested in Simplify VettaFi Private Credit Strategy ETF be worth today?
Limited historical data is available for PCR. The stock has been trading since 2025-09-23.
Has Simplify VettaFi Private Credit Strategy ETF outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare PCR performance over available time periods.
What is Simplify VettaFi Private Credit Strategy ETF's average annual return?
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.